Trial Profile
Apatinib mesylate tablets in the treatment of recurrent glioblastoma, open II single arm clinical study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 12 Jan 2018 New trial record